Sökning: onr:"swepub:oai:gup.ub.gu.se/307526" > Post-SARS-CoV-2-vac...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 04586naa a2200541 4500 | |
001 | oai:gup.ub.gu.se/307526 | |
003 | SwePub | |
008 | 240910s2021 | |||||||||||000 ||eng| | |
024 | 7 | a https://gup.ub.gu.se/publication/3075262 URI |
024 | 7 | a https://doi.org/10.1111/ene.150292 DOI |
040 | a (SwePub)gu | |
041 | a eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Krzywicka, K.4 aut |
245 | 1 0 | a Post-SARS-CoV-2-vaccination cerebral venous sinus thrombosis: an analysis of cases notified to the European Medicines Agency |
264 | c 2021-08-04 | |
264 | 1 | b Wiley,c 2021 |
520 | a Background and purpose Cerebral venous sinus thrombosis (CVST) has been described after vaccination against SARS-CoV-2. The clinical characteristics of 213 post-vaccination CVST cases notified to the European Medicines Agency are reported. Methods Data on adverse drug reactions after SARS-CoV-2 vaccination notified until 8 April 2021 under the Medical Dictionary for Regulatory Activities Term 'Central nervous system vascular disorders' were obtained from the EudraVigilance database. Post-vaccination CVST was compared with 100 European patients with CVST from before the COVID-19 pandemic derived from the International CVST Consortium. Results In all, 213 CVST cases were identified: 187 after AstraZeneca/Oxford (ChAdOx1 nCov-19) vaccination and 26 after a messenger RNA (mRNA) vaccination (25 with Pfizer/BioNTech, BNT162b2, and one with Moderna, mRNA-1273). Thrombocytopenia was reported in 107/187 CVST cases (57%, 95% confidence interval [CI] 50%-64%) in the ChAdOx1 nCov-19 group, in none in the mRNA vaccine group (0%, 95% CI 0%-13%) and in 7/100 (7%, 95% CI 3%-14%) in the pre-COVID-19 group. In the ChAdOx1 nCov-19 group, 39 (21%) reported COVID-19 polymerase chain reaction tests were performed within 30 days of CVST symptom onset, and all were negative. Of the 117 patients with a reported outcome in the ChAdOx1 nCov-19 group, 44 (38%, 95% CI 29%-47%) had died, compared to 2/10 (20%, 95% CI 6%-51%) in the mRNA vaccine group and 3/100 (3%, 95% CI 1%-8%) in the pre-COVID-19 group. Mortality amongst patients with thrombocytopenia in the ChAdOx1 nCov-19 group was 49% (95% CI 39%-60%). Conclusions Cerebral venous sinus thrombosis occurring after ChAdOx1 nCov-19 vaccination has a clinical profile distinct from CVST unrelated to vaccination. Only CVST after ChAdOx1 nCov-19 vaccination was associated with thrombocytopenia. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Medicinska och farmaceutiska grundvetenskaperx Neurovetenskaper0 (SwePub)301052 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Basic Medicinex Neurosciences0 (SwePub)301052 hsv//eng |
653 | a COVID-19 vaccine | |
653 | a CVST | |
653 | a EMA | |
653 | a thrombocytopenia | |
653 | a Neurosciences & Neurology | |
700 | 1 | a Heldner, M. R.4 aut |
700 | 1 | a van Kammen, M. S.4 aut |
700 | 1 | a van Haaps, T.4 aut |
700 | 1 | a Hiltunen, S.4 aut |
700 | 1 | a Silvis, S. M.4 aut |
700 | 1 | a Levi, M.4 aut |
700 | 1 | a Hovinga, J. A. K.4 aut |
700 | 1 | a Jood, Katarina,d 1966u Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för klinisk neurovetenskap,Institute of Neuroscience and Physiology, Department of Clinical Neuroscience4 aut0 (Swepub:gu)xjooka |
700 | 1 | a Lindgren, Erik,d 1993u Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för klinisk neurovetenskap,Institute of Neuroscience and Physiology, Department of Clinical Neuroscience4 aut0 (Swepub:gu)xliere |
700 | 1 | a Tatlisumak, Turgutu Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för klinisk neurovetenskap,Institute of Neuroscience and Physiology, Department of Clinical Neuroscience4 aut0 (Swepub:gu)xtatlt |
700 | 1 | a Putaala, J.4 aut |
700 | 1 | a de Sousa, D. A.4 aut |
700 | 1 | a Middeldorp, S.4 aut |
700 | 1 | a Arnold, M.4 aut |
700 | 1 | a Coutinho, J. M.4 aut |
700 | 1 | a Ferro, J. M.4 aut |
710 | 2 | a Göteborgs universitetb Institutionen för neurovetenskap och fysiologi, sektionen för klinisk neurovetenskap4 org |
773 | 0 | t European Journal of Neurologyd : Wileyg 28:11, s. 3656-3662q 28:11<3656-3662x 1351-5101x 1468-1331 |
856 | 4 | u https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ene.15029 |
856 | 4 8 | u https://gup.ub.gu.se/publication/307526 |
856 | 4 8 | u https://doi.org/10.1111/ene.15029 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy